Stockreport

Vaccinex Announces $3.8 Million Private Placement

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treati [Read more]